Sponsor Pipeline

Alumis Inc Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
0
Recruiting
1
Phase 3
2
Disease Areas
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-29 NCT05739435
Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of ESK-001 in…		 date change Primary completion pushed: 2026-12-01 -> 2027-12-01
2026-07-29 NCT05739435
Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of ESK-001 in…		 date change Completion pushed: 2026-12-30 -> 2027-12-31
Active Trials by Phase
Phase 3
1
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06846541 Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis Plaque Psoriasis Active, Not Recruiting
Phase 2
NCT05966480 Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active… SLE Active, Not Recruiting
NCT05739435 Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of ESK-001 in… Plaque Psoriasis Active, Not Recruiting
Disease Areas
Psoriasis (2) Lupus (SLE) (1)
Get alerts when Alumis Inc's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free